OTC · Financial Statements
Finch Therapeutics Group, Inc. (FNCHQ) Financial Statements
$10.20
OTC: FNCHQ
Market Cap $16.38M
Overview Financials Dividend Finch Therapeutics Group, Inc. most recently reported annual revenue of $0, net profit of $-14.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2020 2021 2022 2023 2024 Revenue $8.0M $19.0M $1.0M $0 $0 Operating Profit $-39.0M $-60.0M $-95.0M $-34.0M $-19.0M Net Profit $-39.0M $-58.0M $-115.0M $-75.0M $-14.0M EPS $-24.39 $-36.72 $-72.12 $-46.59 $-8.64 Op Margin -510.9% -323.7% -11047.6% -31777.6% —
Balance Sheet (USD)
Metric 2020 2021 2022 2023 2024 Total Assets $165.0M $225.0M $163.0M $55.0M $50.0M Total Liabilities $261.0M $23.0M $67.0M $32.0M $41.0M Cash $100.0M $133.0M $71.0M $25.0M $10.0M Borrowings $2.0M $6.0M $52.0M $30.0M $28.0M
Cash Flow (USD)
Metric 2020 2021 2022 2023 2024 Operating Cash Flow $-31.0M $-67.0M $-75.0M $-32.0M — Investing Cash Flow $-5.0M $-32.0M $-4.0M $1.0M — Financing Cash Flow $0 $1.0M $0 $-1.0M — Net Cash Flow $58.0M $36.0M $-62.0M $-46.0M — Free Cash Flow $-34.0M $-83.0M $-77.0M $-32.0M $0
Valuation & Return Ratios
Metric Value PEG Ratio -0.01 EV / EBITDA -2.47 FCF Yield -192.35% Quick Ratio 3.39 Interest Coverage 0.00 Return 1Y -16.67% Return 3Y 54.55% Return 5Y -97.57%
Screens featuring this stock